OTCMKTS:KSPHF Kissei Pharmaceutical (KSPHF) Stock Price, News & Analysis $24.50 0.00 (0.00%) As of 10/15/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartNews and Trends About Kissei Pharmaceutical Stock (OTCMKTS:KSPHF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Kissei Pharmaceutical alerts:Sign Up Key Stats Today's Range$24.50▼$24.5050-Day Range$24.50▼$25.7752-Week Range$23.23▼$31.90VolumeN/AAverage Volume563 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Kissei Pharmaceutical Co., Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacture and marketing of prescription medicines and related healthcare products. The company focuses primarily on therapeutic areas including urology, gastroenterology, nephrology, gynecology and metabolic disorders. Kissei develops and commercializes medicines for conditions such as overactive bladder, urinary disorders and gastrointestinal diseases. Its activities include drug discovery, clinical development, manufacturing and the distribution of pharmaceutical products through Japan’s healthcare system. Founded in 1946 and headquartered in Matsumoto, Nagano, Kissei Pharmaceutical serves the Japanese market and pursues international activities through overseas subsidiaries, licensing arrangements and partnerships. The company also conducts research collaborations intended to expand its product pipeline and support the development of treatments in its specialized therapeutic fields.AI Generated. May Contain Errors. Read More Receive KSPHF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kissei Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KSPHF Stock News HeadlinesKissei Pharmaceutical Reports Progress on Share Buyback ProgramSeptember 3, 2026 | tipranks.comKissei Pharmaceutical Posts Mixed Q1 Results, Lifts Dividends but Cuts FY2027 OutlookAugust 15, 2026 | theglobeandmail.comI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any regular brokerage account gives investors exposure to SpaceX and 66 of its neighbors, without an IPO allocation. He is also naming two space stocks he would consider dumping before December, plus a $14 stock that Elon has personally put his name on.October 16 at 1:00 AM | Behind the Markets (Ad)Jefferies Sticks to Their Buy Rating for Kissei Pharmaceutical Co (KSPHF)May 5, 2026 | theglobeandmail.comKissei Launches Yselty in Japan, Expanding Global Uterine Fibroid Treatment PortfolioMarch 21, 2026 | theglobeandmail.comKissei Pharmaceutical Co (KSPHF) Receives a Buy from DaiwaJanuary 31, 2026 | theglobeandmail.comKissei Pharmaceutical initiated with a neutral at UBSDecember 14, 2025 | msn.comKissei Pharmaceutical Adjusts Dividend Payment DateDecember 1, 2025 | tipranks.comSee More Headlines KSPHF Stock Analysis - Frequently Asked Questions How have KSPHF shares performed this year? Kissei Pharmaceutical's stock was trading at $26.97 at the beginning of the year. Since then, KSPHF shares have decreased by 9.2% and is now trading at $24.50. How do I buy shares of Kissei Pharmaceutical? Shares of KSPHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/16/2026Next Earnings (Estimated)11/04/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:KSPHF CIKN/A Webwww.kissei.co.jp Phone(126) 325-9081FaxN/AEmployees1,786Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (OTCMKTS:KSPHF) was last updated on 10/15/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredSpaceX minted 4400 millionaires in a single daySpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kissei Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kissei Pharmaceutical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
